Navigation Links
Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
Date:6/22/2009

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) is seeking proposals for grant funding for research studies on lupus, an unpredictable and potentially fatal autoimmune disease. Grants will support areas of study in pediatric lupus and adult stem cell transplantation. The purposes of the studies are to advance adult stem cell transplantation research in humans as a treatment for lupus and address key understanding of pediatric/adolescent lupus research issues.

This is the second year of funding for the Michael Jon Barlin Pediatric Lupus Program. There is a special urgency associated with research on pediatric lupus, as lupus in children may develop early and tends to be more severe with multi-organ system involvement. Early and aggressive treatment can have a dramatic, positive impact on disease activity and on the progression of disease. Therefore, new diagnostic and prognostic tests, as well as treatments specifically for children, are more important than ever in addressing this potentially devastating form of lupus.

Stem cells are undifferentiated adult or embryonic cells that give rise to specialized cells, such as blood, bone, heart, etc. While stem cell transplantations are currently being tested and explored in clinics and labs, researchers are only beginning to understand the potential impact and role of adult stem cells in the development and treatment of lupus.

Binding letters of intent must be submitted by July 13, 2009 (extended from July 3). Online applications must be submitted by August 7, 2009. Awards will be announced on September 18, 2009. For additional information, visit the research section of the LFA website at lupus.org.

Although basic science and therapeutic advances are being made, substantial work remains to fully understand the causes, epidemiology, and clinical impact of lupus. The purpose of these grants is to accelerate research related to the causes, treatments, prevention and cure of lupus and to directly sponsor research to test new approaches and develop experimental therapies or treatments. The LFA's national research program, Bringing Down the Barriers, is supported exclusively through donations from the LFA's chapters, private foundations, corporations, and the concerned public.

Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Lupus can be unpredictable and potentially fatal, yet no satisfactory treatment or cure exists. An estimated 1.5 million Americans and at least five million people worldwide have a form of lupus. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure.

The LFA is the nation's foremost nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and its network of nearly 300 chapters, branches, and support groups conduct programs of research, education, and advocacy.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients
2. Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
3. Walk for Lupus Now(TM) at the Orange County Great Park
4. Mary Wilson Brings the Crowd to Their Feet at the Sixth Annual Lupus Foundation of America Awards Gala
5. EHE International and the S.L.E. Lupus Foundation Celebrate Lupus Awareness Month in Rockefeller Plaza
6. Decrease in sense of smell seen in lupus patients
7. Father Breaks Cycling Record To Honor Daughters Fight Against Lupus
8. LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families
9. Birth Control Pills Linked to Lupus Risk
10. Oral contraceptives associated with increased risk of lupus
11. Gene May Explain Womens Heightened Lupus Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: